FMC Corp vs Macy's Inc — how do they compare? FMC Corp trades at $11.53 (market cap $1.36B), while Macy's Inc trades at $24.04 (market cap $6.25B). The key difference: Macy's Inc is far larger — about 4.6× FMC Corp's market cap, and Macy's Inc pays the higher dividend (3.22%). Which is the better fit depends on your goals.
| FMC | M | |
|---|---|---|
Market Cap | $1.36B | $6.25B |
Sector | Basic Materials | Consumer Cyclical |
52-Week High | $43.90 | $25.96 |
52-Week Low | $10.72 | $11.90 |
Enterprise Value | $5.50B | $10.06B |
Dividend Yield | 2.95% | 3.22% |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
Macy's (M) trades at $24.04, up 3.55% today, with a bullish technical signal and positive earnings momentum after beating estimates in three consecutive quarters. The stock shows attractive valuation metrics with a P/E of 9.82 and P/S of 0.29, while recent news highlights strategic initiatives including AI integration and leadership appointments. Cash flow trends improved in 2025 with net cash flow of $273 million, though revenue declined slightly to $23.01 billion.
Outlook remains cautiously optimistic with a consensus price target of $24.83 offering modest upside. Key opportunities include operational efficiency gains and luxury segment growth, while risks involve competitive retail pressures and macroeconomic sensitivity. Institutional interest is growing with Berkshire Hathaway's recent 3 million share purchase (Barron's, June 22, 2026).
Trailing returns across standard periods
Latest headlines on both assets
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →